Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watt

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
American Journal of Epidemiology|August 19, 2007
Risk factors for invasive pneumococcal disease among Navajo adultsJames P Watt, Katherine L O'Brien, Andrea L Benin, et al.
Journal of Clinical Microbiology|November 6, 2004
Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adultsJames P Watt, Katherine L O'Brien, Scott Katz, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligandsAndrew Pike, Susan M Cook, Alan P Watt, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.
Stem Cell Research & Therapy|February 15, 2023
Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambsAlexander Bell, Ashalyn P Watt, Ingrid Dudink, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Vaccine|October 31, 2006
Contributions of Native Americans to the global control of infectious diseasesMathuram Santosham, Raymond Reid, Aruna Chandran, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Mark G Bock, John R Doedens, et al.
Oncotarget|July 24, 2018
Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitisJennifer Nguyen, Jingjing Jiao, Kristin Smoot, et al.
RSC Medicinal Chemistry|September 8, 2025
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an <i>in vivo</i> tool compound for neuroinflammatory disordersDavid Harrison, Andy Billinton, Mark G Bock, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
American Journal of Epidemiology|August 19, 2007
Risk factors for invasive pneumococcal disease among Navajo adultsJames P Watt, Katherine L O'Brien, Andrea L Benin, et al.
Journal of Clinical Microbiology|November 6, 2004
Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adultsJames P Watt, Katherine L O'Brien, Scott Katz, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligandsAndrew Pike, Susan M Cook, Alan P Watt, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complexL J Bristow, P H Hutson, J J Kulagowski, et al.
Stem Cell Research & Therapy|February 15, 2023
Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambsAlexander Bell, Ashalyn P Watt, Ingrid Dudink, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Vaccine|October 31, 2006
Contributions of Native Americans to the global control of infectious diseasesMathuram Santosham, Raymond Reid, Aruna Chandran, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Mark G Bock, John R Doedens, et al.
Oncotarget|July 24, 2018
Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitisJennifer Nguyen, Jingjing Jiao, Kristin Smoot, et al.
RSC Medicinal Chemistry|September 8, 2025
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an <i>in vivo</i> tool compound for neuroinflammatory disordersDavid Harrison, Andy Billinton, Mark G Bock, et al.
Pageof 22